Related Experiment Video
Updated: Jun 29, 2025

12:38
Structure of HIV-1 Capsid Assemblies by Cryo-electron Microscopy and Iterative Helical Real-space Reconstruction
Published on: August 9, 2011
17.4K
IP6 and PF74 affect HIV-1 Capsid Stability through Modulation of Hexamer-Hexamer Tilt Angle Preference.
Biorxiv : the Preprint Server for Biology
|April 1, 2024
Summary
Small molecules like IP6 and PF74 modulate the structural flexibility of the HIV-1 capsid. These findings offer insights into HIV-1 capsid dynamics and inform structure-based drug design.
Area of Science:
- Structural biology
- Virology
- Computational biophysics
Background:
- The human immunodeficiency virus type 1 (HIV-1) capsid is essential for viral replication, mediating nuclear entry and genome integration.
- Emerging therapeutics, like lenacapavir, target non-enzymatic viral proteins, highlighting the capsid as a drug target.
- Molecules such as inositolhexakisphosphate (IP6) and PF74 are known to affect capsid stability, but their precise mechanisms remain unclear.
Approach:
- Employed systematic atomistic simulations to investigate the impact of IP6 and PF74 on capsid oligomer dynamics.
- Compared the effects of IP6 (bound at the central pore) and PF74 (bound at the FG-binding site) on hexamers and pentamers.
- Analyzed the free energy profiles of inter-hexamer binding and angular deformations to assess structural flexibility.
Key Points:
- Neither IP6 nor PF74 significantly altered the free energy of binding between neighboring hexamers.
- Both molecules impacted the free energy profiles associated with angular deformations, affecting capsid curvature.
- IP6 stabilizes hexamers in flatter configurations, while PF74 favors intermediate tilt angles between hexamers.
Conclusions:
- HIV-1 capsid structural instability is a natural property modulated by small molecules binding to specific sites.
- IP6 and PF74 exhibit distinct effects on capsid flexibility despite potential similarities in protein-protein interactions.
- Findings provide a detailed model of HIV-1 capsid-small molecule interactions, guiding structure-based drug design and experimental strategies.
More Related Videos
07:10Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
Published on: September 14, 2014
14.4K
10:50Assessment of Immunologically Relevant Dynamic Tertiary Structural Features of the HIV-1 V3 Loop Crown R2 Sequence by ab initio Folding
Published on: September 15, 2010
9.6K